139 related articles for article (PubMed ID: 21454209)
21. Waldenström's macroglobulinemia-associated renal amyloidosis presenting as a solitary lung mass.
Chung YY; Wang CC; Lai KJ; Chang CC
Ren Fail; 2012; 34(9):1173-6. PubMed ID: 22950818
[TBL] [Abstract][Full Text] [Related]
22. Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients.
Terpos E; Tasidou A; Eleftherakis-Papaiakovou E; Christoulas D; Gavriatopoulou M; Gkotzamanidou M; Roussou M; Kastritis E; Papadaki T; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):115-7. PubMed ID: 21454208
[TBL] [Abstract][Full Text] [Related]
23. [Histological study of the bone marrow in 96 cases of Waldenstrom's macroglobulinemia. An evaluation with clinical, haematological and biological data (author's transl)].
Stachowiak J; Duhamel G; Najman A; Gorin NC
Sem Hop; 1979 Oct 18-25; 55(35-36):1569-74. PubMed ID: 231825
[TBL] [Abstract][Full Text] [Related]
24. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
25. Establishment of an animal model for Waldenström's macroglobulinemia.
Tsingotjidou AS; Emmanouilides CE; Siotou E; Poutahidis T; Xagorari A; Loukopoulos P; Sotiropoulos D; Bekiari C; Doulberis M; Givissis P; Fassas A; Anagnostopoulos A
Exp Hematol; 2009 Apr; 37(4):469-76. PubMed ID: 19302921
[TBL] [Abstract][Full Text] [Related]
26. Lymph node involvement in Waldenström's macroglobulinemia.
Aozasa K; Uda H
Acta Pathol Jpn; 1980 May; 30(3):437-44. PubMed ID: 6771962
[TBL] [Abstract][Full Text] [Related]
27. Extramedullary Waldenström macroglobulinemia.
Banwait R; Aljawai Y; Cappuccio J; McDiarmid S; Morgan EA; Leblebjian H; Roccaro AM; Laubach J; Castillo JJ; Paba-Prada C; Treon S; Redd R; Weller E; Ghobrial IM
Am J Hematol; 2015 Feb; 90(2):100-4. PubMed ID: 25349134
[TBL] [Abstract][Full Text] [Related]
28. The bone marrow microenvironment in waldenstrom macroglobulinemia.
Ghobrial IM; Maiso P; Azab A; Liu Y; Zhang Y; Issa G; Azab F; Sacco A; Quang P; Ngo H; Roccaro A
Ther Adv Hematol; 2011 Aug; 2(4):267-72. PubMed ID: 23556094
[TBL] [Abstract][Full Text] [Related]
29. Bone-marrow patterns and survival in Waldenström's macroglobulinaemia.
Chelazzi G; Bettini R; Pinotti G
Lancet; 1979 Nov; 2(8149):965-6. PubMed ID: 91063
[No Abstract] [Full Text] [Related]
30. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
[TBL] [Abstract][Full Text] [Related]
31. [Waldenstrom's macroglobulinemia in the lymphoid follicle of the palatine amygdala. Ultrastructural study of 3 cases].
Gil-Carcedo LM
Sangre (Barc); 1973; 18(2):157-69. PubMed ID: 4356700
[No Abstract] [Full Text] [Related]
32. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
33. Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia.
Pals ST; Kersten MJ; Spaargaren M
Best Pract Res Clin Haematol; 2016 Jun; 29(2):161-168. PubMed ID: 27825462
[TBL] [Abstract][Full Text] [Related]
34. Role of proteasome inhibition in Waldenström's macroglobulinemia.
Roccaro AM; Sacco A; Leleu X; Azab AK; Azab F; Runnels J; Jia X; Ngo HT; Melhem M; Moreau AS; Ghobrial IM
Clin Lymphoma Myeloma; 2009 Mar; 9(1):94-6. PubMed ID: 19362985
[TBL] [Abstract][Full Text] [Related]
35. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
[TBL] [Abstract][Full Text] [Related]
36. [Waldenström's macroglobulinemia with myeloid splenomegaly].
Bousser J; Dao C; Zittoun R; Mignot L
Ann Med Interne (Paris); 1976; 127(6-7):483-9. PubMed ID: 823855
[No Abstract] [Full Text] [Related]
37. Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia.
García-Sanz R; Ocio E; Caballero A; Magalhães RJ; Alonso J; López-Anglada L; Villaescusa T; Puig N; Hernández JM; Fernández-Calvo J; Aguilar A; Martín A; López R; Paiva B; Orfao A; Vidriales B; San-Miguel JF; Del Carpio D
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):168-71. PubMed ID: 21856552
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
[TBL] [Abstract][Full Text] [Related]
40. "Waldenström's macroglobulinemia" terminating in immunoblastic sarcoma. A case report.
Abe M; Takahashi K; Mori N; Kojima M
Cancer; 1982 Jun; 49(12):2580-6. PubMed ID: 6804086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
